Platelets induce apoptosis via membrane-bound FasL

Blood

Volumn 126, Issue 12, 2015, Pages 1483-1493

  Schleicher, Rebecca I ^a,b   Reichenbach, Frank ^c,d   Kraft, Peter ^e   Kumar, Anil ^f   Lescan, Mario ^b   Todt, Franziska ^c   Göbel, Kerstin ^g   Hilgendorf, Ingo ^d   Geisler, Tobias ^b   Bauer, Axel ^b   Olbrich, Marcus ^a,b   Schaller, Martin ^b   Wesselborg, Sebastian ^h   O'Reilly, Lorraine ⁱ   Meuth, Sven G ^g   Schulze Osthoff, Klaus ^j   Gawaz, Meinrad ^b   Li, Xuri ^k   Kleinschnitz, Christoph ^e   Edlich, Frank ^c,d   Langer, Harald F ^a,b   more..

^a Department of Cardiovascular Medicine Section for Cardioimmunology   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Institute of Biochemistry and Molecular Biology   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^f NATIONAL EYE INSTITUTE   (United States)

^g UNIVERSITY OF MÜNSTER   (Germany)

^h HEINRICH HEINE UNIVERSITY   (Germany)

ⁱ WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^j UNIVERSITY OF TÜBINGEN   (Germany)

^k SUN YAT SEN UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID; PROTEIN BAK; PROTEIN BAX;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; TARGET CELL; THROMBOCYTE; THROMBOCYTE ACTIVATION; TISSUE INJURY; ANIMAL; C57BL MOUSE; CELL CULTURE; CEREBROVASCULAR ACCIDENT; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; PATHOLOGY;

ANIMALS; APOPTOSIS; BLOOD PLATELETS; CELLS, CULTURED; FAS LIGAND PROTEIN; HUMANS; INFLAMMATION; MICE, INBRED C57BL; NEURONS; PLATELET ACTIVATION; STROKE;

EID: 84942898732     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-12-544445     Document Type: Article

References (67)

1. Wagner DD, Frenette PS. The vessel wall and its interactions. Blood. 2008;111(11):5271-5281.
2. Varga-Szabo D, Pleines I, Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol. 2008;28(3):403-412.
3. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med. 2008;359(12):1261-1270.
4. Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res. 2007; 100(12):1673-1685.
5. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115(12):3378-3384.
6. Stellos K, Kopf S, Paul A, et al. Platelets in regeneration. Semin Thromb Hemost. 2010;36(2): 175-184.
7. Langer HF, Gawaz M. Platelets in regenerative medicine. Basic Res Cardiol. 2008;103(4): 299-307.
8. Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22(9):913-922.
9. Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost. 2011;9(suppl 1):92-104.
10. Jackson SP. Arterial thrombosis-insidious, unpredictable and deadly. Nat Med. 2011;17(11): 1423-1436.
11. Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost. 2008;99(3):480-486.
12. Siddiqui TI, Kumar K S A, Dikshit DK. Platelets and atherothrombosis: causes, targets and treatments for thrombosis. Curr Med Chem. 2013; 20(22):2779-2797.
13. Langer HF, Choi EY, Zhou H, et al. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res. 2012; 110(9):1202-1210.
14. Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagendependent microparticle production. Science. 2010;327(5965):580-583.
15. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011; 147(4):742-758.
16. Green DR, Galluzzi L, Kroemer G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science. 2011;333(6046): 1109-1112.
17. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE. Cell death. N Engl J Med. 2009;361(16): 1570-1583.
18. Mc Guire C, Beyaert R, van Loo G. Death receptor signalling in central nervous system inflammation and demyelination. Trends Neurosci. 2011;34(12):619-628.
19. Walker NI, Harmon BV, Gobé GC, Kerr JF. Patterns of cell death. Methods Achiev Exp Pathol. 1988;13:18-54.
20. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9(1):47-59.
21. Eskes R, Antonsson B, Osen-Sand A, et al. Baxinduced cytochrome C release from mitochondria is independent of the permeability transition pore but highly dependent on Mg21 ions. J Cell Biol. 1998;143(1):217-224.
22. Annis MG, Soucie EL, Dlugosz PJ, et al. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005;24(12):2096-2103.
23. Edlich F, Banerjee S, Suzuki M, et al. Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol. Cell. 2011;145(1):104-116.
24. Llambi F, Moldoveanu T, Tait SW, et al. A unified model of mammalian BCL-2 protein family interactions at the mitochondria. Mol Cell. 2011; 44(4):517-531.
25. Siegel RM, Frederiksen JK, Zacharias DA, et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science. 2000;288(5475):2354-2357.
26. Aggarwal BB. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol. 2003;3(9):745-756.
27. Kaufmann T, Strasser A, Jost PJ. Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ. 2012;19(1):42-50.
28. O' Reilly LA, Tai L, Lee L, et al. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature. 2009;461(7264):659-663.
29. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94(4): 491-501.
30. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94(4):481-490.
31. Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: The Bernard-Soulier syndrome. Proc Natl Acad Sci USA. 2000;97(6):2803-2808.
32. Mabrouk I, Buart S, Hasmim M, et al. Prevention of autoimmunity and control of recall response to exogenous antigen by Fas death receptor ligand expression on T cells. Immunity. 2008;29(6): 922-933.
33. Langer HF, Stellos K, Steingen C, et al. Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. J Mol Cell Cardiol. 2009;47(2):315-325.
34. Lonsdorf AS, Krämer BF, Fahrleitner M, et al. Engagement of aIIbb3 (GPIIb/IIIa) with anb3 integrin mediates interaction of melanoma cells with platelets: A connection to hematogenous metastasis. J Biol Chem. 2012;287(3):2168-2178.
35. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012;120(15):e73-e82.
36. Herrmann AM, Göbel K, Simon OJ, et al. Glatiramer acetate attenuates pro-inflammatory T cell responses but does not directly protect neurons from inflammatory cell death. Am J Pathol. 2010;177(6):3051-3060.
37. Langer HF, Chung KJ, Orlova VV, et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood. 2010;116(22):4395-4403.
38. Stellos K, Sauter R, Fahrleitner M, et al. Binding of oxidized low-density lipoprotein on circulating platelets is increased in patients with acute coronary syndromes and induces platelet adhesion to vascular wall in vivo-brief report. Arterioscler Thromb Vasc Biol. 2012;32(8): 2017-2020.
39. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activationdependent monoclonal antibodies and flow cytometry. Blood. 1987;70(1):307-315.
40. Scorrano L, Oakes SA, Opferman JT, et al. BAX and BAK regulation of endoplasmic reticulum Ca21: A control point for apoptosis. Science. 2003;300(5616):135-139.
41. Li Y, Zhang F, Nagai N, et al. VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest. 2008;118(3):913-923.
42. Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013; 121(4):679-691.
43. Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation. 2007;115(17):2323-2330.
44. Kraft P, Schwarz T, Göb E, et al. The phosphodiesterase-4 inhibitor rolipram protects from ischemic stroke in mice by reducing bloodbrain- barrier damage, inflammation and thrombosis. Exp Neurol. 2013;247:80-90.
45. Langhauser F, Göb E, Kraft P, et al. Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood. 2012;120(19):4082-4092.
46. Galluzzi L, Aaronson SA, Abrams J, et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009;16(8): 1093-1107.
47. Ahmad R, Menezes J, Knafo L, Ahmad A. Activated human platelets express Fas-L and induce apoptosis in Fas-positive tumor cells. J Leukoc Biol. 2001;69(1):123-128.
48. Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet. 1999;33:29-55.
49. Lindsten T, Ross AJ, King A, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell. 2000;6(6): 1389-1399.
50. Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res. 2013;112(11): 1506-1519.
51. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Litwack G, Alnemri ES. Molecular ordering of the Fas-apoptotic pathway: The Fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA. 1996;93(25): 14486-14491.
52. Huang DC, Hahne M, Schroeter M, et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA. 1999;96(26): 14871-14876.
53. Hohlbaum AM, Moe S, Marshak-Rothstein A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J Exp Med. 2000;191(7):1209-1220.
54. Cullen SP, Henry CM, Kearney CJ, et al. Fas/CD95-induced chemokines can serve as "findme" signals for apoptotic cells. Mol Cell. 2013; 49(6):1034-1048.
55. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature. 2009;459(7245):428-432.
56. Kraft P, Göb E, Schuhmann MK, et al. FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection. Stroke. 2013;44(11):3202-3210.
57. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995; 270(5239):1189-1192.
58. Semple JW. Platelets play a direct role in sepsisassociated endothelial cell death. Thromb Haemost. 2008;99(2):249.
59. Kuckleburg CJ, Tiwari R, Czuprynski CJ. Endothelial cell apoptosis induced by bacteriaactivated platelets requires caspase-8 and -9 and generation of reactive oxygen species. Thromb Haemost. 2008;99(2):363-372.
60. Arabanian LS, Kujawski S, Habermann I, Ehninger G, Kiani A. Regulation of fas/fas ligandmediated apoptosis by nuclear factor of activated T cells in megakaryocytes. Br J Haematol. 2012; 156(4):523-534.
61. Langer HF, May AE, Vestweber D, De Boer HC, Hatzopoulos AK, Gawaz M. Platelet-induced differentiation of endothelial progenitor cells. Semin Thromb Hemost. 2007;33(2):136-143.
62. Galluzzi L, Kepp O, Trojel-Hansen C, Kroemer G. Mitochondrial control of cellular life, stress, and death. Circ Res. 2012;111(9):1198-1207.
63. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science. 2012;337(6098): 1062-1065.
64. Clark SR, Ma AC, Tavener SA, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. 2007; 13(4):463-469.
65. Vosler PS, Chen J. Potential molecular targets for translational stroke research. Stroke. 2009; 40(3 suppl):S119-S120.
66. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399-415.
67. Tymianski M. Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci. 2011;14(11):1369-1373.